Redcare Pharmacy N.V.
SHPPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.23 | 0.81 | -2.52 | -0.10 |
| FCF Yield | -0.74% | 2.80% | -10.33% | -1.61% |
| EV / EBITDA | 101.37 | 19.44 | -27.39 | -46.07 |
| Quality | ||||
| ROIC | -4.95% | -1.73% | -10.34% | -9.40% |
| Gross Margin | 23.02% | 24.48% | 27.55% | 25.14% |
| Cash Conversion Ratio | -0.57 | -3.55 | 0.42 | -0.18 |
| Growth | ||||
| Revenue 3-Year CAGR | 25.32% | 19.26% | 7.55% | 14.79% |
| Free Cash Flow Growth | -186.18% | 128.12% | -162.14% | 11.28% |
| Safety | ||||
| Net Debt / EBITDA | 5.35 | 3.16 | -5.23 | 0.25 |
| Interest Coverage | -5.01 | -2.16 | -8.13 | -7.67 |
| Efficiency | ||||
| Inventory Turnover | 11.86 | 10.00 | 8.75 | 8.22 |
| Cash Conversion Cycle | 12.62 | 16.57 | 21.96 | 18.12 |